Related Experiment Video
Updated: Apr 19, 2026
Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted
Maja Sochalska1, Selma Tuzlak1, Alexander Egle2
1Division of Developmental Immunology, Biocenter, Medical University Innsbruck, Austria.
Abstract:
Cell survival depends on the maintenance of mitochondrial integrity controlled by a well-balanced interplay between anti- and pro-apoptotic B cell lymphoma 2 (Bcl2) family members. Given their frequent deregulation in human pathologies, including autoimmunity and cancer, significant research efforts have increased our molecular understanding of how Bcl2 proteins control cell death. This has fostered the development of small non-peptidic compounds, so-called BH3-mimetics, that show excellent prospects of passing clinical trials and entering daily use for targeted therapy. Possible limitations in clinical application may, to a certain degree, be predicted from loss-of-function phenotypes gathered from studies using gene-modified mice that we attempt to summarize and discuss in this context.
Insights
Mitochondrial integrity is crucial for cell survival, regulated by B cell lymphoma 2 (Bcl2) proteins. Understanding Bcl2 family members aids in developing targeted therapies like BH3-mimetics for cancer and autoimmune diseases.
Area of Science:
- Molecular biology
- Cellular biology
- Biochemistry
Background:
- Cell survival relies on mitochondrial integrity, governed by B cell lymphoma 2 (Bcl2) protein family members.
- Dysregulation of Bcl2 proteins is implicated in human diseases such as cancer and autoimmunity.
- Extensive research has elucidated the molecular mechanisms by which Bcl2 proteins regulate cell death pathways.
Purpose of the Study:
- To summarize and discuss loss-of-function phenotypes from gene-modified mouse studies.
- To predict potential limitations for clinical applications of BH3-mimetics.
- To enhance the understanding of Bcl2 protein roles in cell death and disease.
Main Methods:
- Review of existing literature on gene-modified mouse models.
- Analysis of loss-of-function phenotypes associated with Bcl2 family members.
- Synthesis of data to predict therapeutic limitations.
Main Results:
- Loss-of-function studies provide insights into Bcl2 protein functions.
- Phenotypic analysis helps anticipate challenges in BH3-mimetic therapy.
- Understanding protein interplay is key to targeted treatment strategies.
Conclusions:
- Gene-modified mouse studies are valuable for predicting clinical outcomes of targeted therapies.
- BH3-mimetics show promise but may face limitations predictable from Bcl2 protein functions.
- Further research integrating molecular understanding and preclinical data is essential for effective therapeutic development.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:31The Intrinsic Apoptotic Pathway
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:26Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
02:23Abnormal Proliferation